BioStem,
PRISM MarketView,
OTC Markets,
Biotech,
OTC,
Stock Market,
Wound Care,
Healthcare,
PRISM DigitalMedia,
PRISM MediaWire
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
Company to Host a Conference Call and Webcast on November 14, 2023, at 10:30 am EDT
Study to support differentiated efficacy of Vendaje® structural tissue allograft
POMPANO BEACH, FLORIDA, October 18, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenera...
Premier Press Release Services
Newswire Reimagined: Reach more investors, media and customers with precision targeting.